UY29626A1 - NON-STEROID MODULATORS OF PROGESTERONE RECEPTORS - Google Patents

NON-STEROID MODULATORS OF PROGESTERONE RECEPTORS

Info

Publication number
UY29626A1
UY29626A1 UY29626A UY29626A UY29626A1 UY 29626 A1 UY29626 A1 UY 29626A1 UY 29626 A UY29626 A UY 29626A UY 29626 A UY29626 A UY 29626A UY 29626 A1 UY29626 A1 UY 29626A1
Authority
UY
Uruguay
Prior art keywords
therapy
prevention
progesterone receptors
hormone
steroid modulators
Prior art date
Application number
UY29626A
Other languages
Spanish (es)
Inventor
Ulrike Fuhrmann
Wolfgang Schwede
Ulrich Bothe
Norbert Schmees
Carsten Moller
Anja Schmidt
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of UY29626A1 publication Critical patent/UY29626A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/88Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/94Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/83Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Furan Compounds (AREA)

Abstract

La presente invención se refiere a moduladores no esteroides del receptor de progesterona de la fórmula general I, a su uso para la preparación de medicamentos, así como a las composiciones farmacéuticas que contienen estos compuestos. Los compuestos según la invención son apropiados para la terapia y la prevención de enfermedades ginecológicas tales como endometriosis, leiomiomas de útero, hemorragias disfuncionales y dismenorrea y para la terapia y la prevención de tumores dependientes de hormonas y para el uso para el control de la fertilidad femenina y para la terapia de reemplazo hormonal.The present invention relates to non-steroidal progesterone receptor modulators of the general formula I, to their use for the preparation of medicaments, as well as to pharmaceutical compositions containing these compounds. The compounds according to the invention are suitable for the therapy and prevention of gynecological diseases such as endometriosis, uterine leiomyomas, dysfunctional hemorrhages and dysmenorrhea and for the therapy and prevention of hormone-dependent tumors and for use for fertility control. female and for hormone replacement therapy.

UY29626A 2005-06-24 2006-06-26 NON-STEROID MODULATORS OF PROGESTERONE RECEPTORS UY29626A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005030294A DE102005030294A1 (en) 2005-06-24 2005-06-24 Nonsteroidal progesterone receptor modulators

Publications (1)

Publication Number Publication Date
UY29626A1 true UY29626A1 (en) 2007-01-31

Family

ID=36716643

Family Applications (1)

Application Number Title Priority Date Filing Date
UY29626A UY29626A1 (en) 2005-06-24 2006-06-26 NON-STEROID MODULATORS OF PROGESTERONE RECEPTORS

Country Status (22)

Country Link
EP (1) EP1899315A1 (en)
JP (1) JP2008543911A (en)
KR (1) KR20080018275A (en)
CN (1) CN101248056A (en)
AR (1) AR057409A1 (en)
AU (1) AU2006261049A1 (en)
BR (1) BRPI0612305A2 (en)
CA (1) CA2611900A1 (en)
CR (1) CR9595A (en)
DE (1) DE102005030294A1 (en)
DO (1) DOP2006000150A (en)
EA (1) EA200702604A1 (en)
EC (1) ECSP078043A (en)
GT (1) GT200600272A (en)
IL (1) IL188022A0 (en)
MX (1) MX2008000070A (en)
NO (1) NO20080441L (en)
PE (1) PE20070170A1 (en)
TW (1) TW200738665A (en)
UY (1) UY29626A1 (en)
WO (1) WO2006136462A1 (en)
ZA (1) ZA200800689B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY30805A1 (en) * 2006-12-21 2008-07-31 Bayer Schering Pharma Ag NON-STEROID MODULATORS OF PROGESTERONE RECEPTORS
DE102007032800A1 (en) * 2007-07-10 2009-01-15 Bayer Schering Pharma Aktiengesellschaft Nonsteroidal progesterone receptor modulators
DE102007058747A1 (en) * 2007-12-05 2009-06-10 Bayer Schering Pharma Aktiengesellschaft Nonsteroidal progesterone receptor modulators
TWI477276B (en) * 2008-04-28 2015-03-21 Repros Therapeutics Inc Antiprogestin dosing regimens
US10328022B2 (en) 2012-05-31 2019-06-25 Repros Therapeutics Inc. Formulations and methods for vaginal delivery of antiprogestins
WO2014070517A1 (en) 2012-11-02 2014-05-08 Repros Therapeutics Inc. Methods and compositions for treating progesterone-dependent conditions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19723722A1 (en) * 1997-05-30 1998-12-10 Schering Ag Nonsteroidal progestogens
CN1353717A (en) * 1999-05-04 2002-06-12 莱加制药公司 Tetracyclic progesterone receptor modulator compounds and methods
US6358948B1 (en) * 1999-05-04 2002-03-19 American Home Products Corporation Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
AU2003202216A1 (en) * 2002-01-14 2003-07-30 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof
EP1482925B1 (en) * 2002-03-11 2007-01-17 Schering AG 5-(2-hydroxy-3-'1-(3-trifluoromethylphenyl)-cyclopropl]-propionylamino)-phtalide and related compounds with progesterone receptor modulating activity for use in fertility control and hormone replacement therapy
DE10346939A1 (en) * 2003-10-06 2005-05-19 Schering Ag New arylalkanol derivatives used for treating e.g. respiratory diseases, joint diseases, vascular inflammations, skin disorders, kidney and liver diseases and neurological diseases

Also Published As

Publication number Publication date
AU2006261049A1 (en) 2006-12-28
EP1899315A1 (en) 2008-03-19
GT200600272A (en) 2007-08-20
DE102005030294A1 (en) 2007-01-04
BRPI0612305A2 (en) 2010-11-03
PE20070170A1 (en) 2007-03-02
DOP2006000150A (en) 2006-12-31
ECSP078043A (en) 2008-01-23
NO20080441L (en) 2008-03-07
AR057409A1 (en) 2007-12-05
JP2008543911A (en) 2008-12-04
MX2008000070A (en) 2008-03-19
KR20080018275A (en) 2008-02-27
TW200738665A (en) 2007-10-16
ZA200800689B (en) 2009-07-29
IL188022A0 (en) 2008-03-20
CN101248056A (en) 2008-08-20
WO2006136462A1 (en) 2006-12-28
CA2611900A1 (en) 2006-12-28
CR9595A (en) 2008-05-05
EA200702604A1 (en) 2008-06-30

Similar Documents

Publication Publication Date Title
CU20120175A7 (en) COMPOUNDS DERIVED FROM 6,7-DIHIDRO-5H-BENZO [7] ANNULARS
ECSP18047708A (en) 17-HYDROXY-17-PENTAFLUOROETHYL-ESTRA-4,9 (10) -DIEN-11-ARYL DERIVATIVES AS PROGESTERONE ANTAGONISTS AND PROCEDURES FOR THEIR PREPARATION
SV2010003580A (en) NEW AGONISTS OF GLUCOCORTICOID RECEPTORS
CR10875A (en) DERIVATIVES OF ESTER AND AMIDA OF INDAZOLILO FOR THE TREATMENT OF DISEASES MEDIATED BY A GLUCOCORTICOID RECEPTOR
AR054586A1 (en) USE OF PROGESTERONE RECEIVER MODULATORS
UY29626A1 (en) NON-STEROID MODULATORS OF PROGESTERONE RECEPTORS
CR10489A (en) PHENYL-PIRAZOL DERIVATIVES AS LEGANDS OF NON-STEROID GLUCOCORTICOID RECEPTORS
CU20140064A7 (en) DERIVATIVES OF 6,7- DIHIDRO-5H-BENZO [7] CANCELLATION, PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL PRODUCTS THAT INCLUDE THE SAME AND ITS USE IN THE PREPARATION OF MEDICINES
UY29625A1 (en) USE OF NON-STEROID MODULATORS OF PROGESTERONE RECEPTORS
CR20190379A (en) Estrogen receptor modulators
ECSP078044A (en) NON-STEROID PROGESTERONE RECEIVER MODULATORS
CR9627A (en) CYANOPYRROLE-SULFONAMIDE PROGESTERONE RECEPTOR MODULATORS AND USES THEREOF
UY30805A1 (en) NON-STEROID MODULATORS OF PROGESTERONE RECEPTORS
UY30815A1 (en) NON-STEROID MODULATORS OF THE PROGESTERONE RECEIVER
CU20090109A7 (en) INDAZOLIL ESTER AND AMIDA DERIVATIVES FOR THE TREATMENT OF DISEASES MEDIATED BY A GLUCOCORTICOID RECEPTOR

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20160916